NFKB1 and breast carcinoma: SIN was proven to be more effective than cyclopamine (10 mM in vitro and 120 mg/kg in vivo) in curbing the lung metastasis of breast cancer in vivo and in vitro and in inhibiting NF-κB activation and the NF-κB-mediated Shh signaling pathway [30].